Hybrid eventIn-person & virtual
June 24–26, 2027Rome, Italy
Session Track · Neurology 2027 · Track 16

Brain Tumors and Neuro-Oncology at Neurology 2027

Part of the Neurology 2027 scientific program · Rome, Italy · June 24–26, 2027

About the Brain Tumors and Neuro-Oncology Session

Brain tumors and neuro-oncology focus on the diagnosis, treatment, and management of tumors affecting the central nervous system, including gliomas, meningiomas, and metastatic brain tumors. Researchers are advancing our understanding of the molecular and genetic factors driving tumor growth and resistance to therapy. Targeted therapies, such as immunotherapy and gene editing, offer new avenues for treating these aggressive conditions. Neuro-oncology also emphasizes the integration of advanced imaging techniques, such as functional MRI and PET scans, to accurately localize tumors and guide surgical intervention. As personalized medicine continues to evolve, the field aims to offer more precise and effective treatments, ultimately improving survival rates and quality of life for patients with brain tumors. The role of novel biomarkers is also gaining attention, enabling earlier detection and tailored therapeutic strategies.

Featured Speakers — Brain Tumors and Neuro-Oncology 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Brain Tumors and Neuro-Oncology Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at Neurology 2027

Why Attend the Brain Tumors and Neuro-Oncology Conference 2027

Present Your Research

Oral and poster slots for original Brain Tumors and Neuro-Oncology work, reviewed by the scientific committee.

Network Globally

Meet researchers, academics, and practitioners from around the world throughout the conference.

Learn from Keynotes

Plenary lectures from leading voices shaping Brain Tumors and Neuro-Oncology research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join Neurology 2027 for the Brain Tumors and Neuro-Oncology track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Brain Tumors and Neuro-Oncology Conference 2027 — FAQs

What is the Brain Tumors and Neuro-Oncology track at Neurology 2027?

The Brain Tumors and Neuro-Oncology track is a dedicated stream within Neurology 2027 covering the latest research, innovation, and best practice in Brain Tumors and Neuro-Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Brain Tumors and Neuro-Oncology sessions?

Researchers, academics, practitioners, doctoral students, and industry professionals with an interest in Brain Tumors and Neuro-Oncology are all welcome — whether presenting or attending.

Can I present my research in the Brain Tumors and Neuro-Oncology track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.

Is virtual attendance available for Brain Tumors and Neuro-Oncology sessions?

Yes. Neurology 2027 is a hybrid conference — attend the Brain Tumors and Neuro-Oncology track in person in Rome or join live online, with on-demand access afterward.

Join the Neurology 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us